Status:
TERMINATED
Assessment of Hematopoietic Recovery Following Chemotherapy for Non-Hodgkin's Lymphoma
Lead Sponsor:
University of Oklahoma
Collaborating Sponsors:
Midwest Medical Isotopes
Conditions:
Non-Hodgkin's Lymphoma
Eligibility:
All Genders
18+ years
Brief Summary
A study to determine the accuracy of FLT-PET in quantifying tumor cell proliferation at the initial staging of patients with Non-Hodgkin's Lymphoma in comparison wit the "gold standard" FDG-PET.
Detailed Description
The first primary objective reflects a necessary and preliminary requirement: to reproduce published results and validate the use of FLT-PET. In this study, 35 patients will be selected to undergoing ...
Eligibility Criteria
Inclusion
- 18 years or older
- Women must not be pregnant or breast feeding
- Histologic diagnosis of non-Hodgkin's lymphoma (any stage)
- Must undergo treatment with chemotherapy and/or radiotherapy
Exclusion
- May not have received previous therapy with radiopharmaceuticals
- May not have received prior therapy with cytotoxic chemotherapy and/or monoclonal antibodies
Key Trial Info
Start Date :
October 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
35 Patients enrolled
Trial Details
Trial ID
NCT00775957
Start Date
October 1 2008
Last Update
September 28 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma, United States, 73104